New paths in human cancer serology - PubMed (original) (raw)

Comment

New paths in human cancer serology

L J Old et al. J Exp Med. 1998.

No abstract available

PubMed Disclaimer

Comment on

Similar articles

Cited by

References

    1. Knuth A, Danowski B, Oettgen HF, Old LJ. T-cell–medicated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2–dependent T cell cultures. Proc Natl Acad Sci USA. 1984;81:3511–3515. - PMC - PubMed
    1. Traversari C, van der Bruggen P, Van den Eynde B, Hainaut P, Lemoine C, Ohta N, Old LJ, Boon T. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics. 1992;35:145–152. - PubMed
    1. van der Bruggen P, Traversari C, Chomez P, Lurquin C, Deplaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991;254:1643–1647. - PubMed
    1. Sahin U, Türeci Ö, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA. 1995;92:11810–11813. - PMC - PubMed
    1. Türeci Ö, Sahin U, Pfreundschuh M. Serological analysis of human tumor antigens: molecular definition and implications. Mol Med Today. 1997;3:342–349. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources